News & Updates
Filter by Specialty:

Urological prosthetic surgery: Which men are at risk of postoperative thromboembolism?
Some men who undergo artificial urinary sphincter (AUS) and inflatable penile prosthesis (IPP) surgery encounter a venous thromboembolism (VTE) event within 90 days of their operation, reports a study.
Urological prosthetic surgery: Which men are at risk of postoperative thromboembolism?
27 Sep 2022
Better cardiovascular health wards off dementia in older adults
Improvements in cardiovascular health (CVH) appear to exert a strong protective effect against dementia in older Asians, reports a recent Korea study.
Better cardiovascular health wards off dementia in older adults
27 Sep 2022
Antihypertensive dosing TIME does not affect CV outcomes
Timing of antihypertensive medication intake, be it in the morning or evening, does not appear to affect the risk of cardiovascular death or hospitalization for non-fatal myocardial infarction (MI) or non-fatal stroke, according to results of the TIME trial presented at ESC 2022.
Antihypertensive dosing TIME does not affect CV outcomes
26 Sep 2022
Does frozen embryo transfer up hypertension risk during pregnancy?
The risk of hypertensive disorders in pregnancy (HDP) is increased following assisted reproductive technology (ART) using frozen embryo transfer (FET) compared with after fresh embryo transfer or natural conception, according to results of a study presented at ESHRE 2022.
Does frozen embryo transfer up hypertension risk during pregnancy?
25 Sep 2022
Evolocumab safety, efficacy affirmed in Arabic patients
PCSK9 inhibition with evolocumab produces clinically meaningful and sustained reductions in certain lipid parameters in a predominantly Arabic population of individuals with familial hypercholesterolaemia (FH) and other non-FH indications, according to a study.
Evolocumab safety, efficacy affirmed in Arabic patients
23 Sep 2022
DANFLU-1: High-dose quadrivalent flu vax reduces hospitalization, death in older adults
Older adults who receive a high-dose quadrivalent influenza vaccine have a 49 percent reduced risk of death and a 64 percent reduced risk of hospitalization for influenza or pneumonia compared with those who receive a standard-dose vaccine, results of the DANFLU-1 study showed.